EDIT vs TRMB · rev $32.3M vs P/E 26, rev $3.68B
Editas Medicine Inc (EDIT) versus Trimble Inc (TRMB) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Trimble Inc (TRMB) is a scientific & technical instruments company listed on NASDAQ.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported TRMB revenue for 2025-01-03 was $3.68B. Net income was $1.50B. Revenue was down 3.0% from 2023-12-29 to 2025-01-03. TRMB currently screens at market cap $11.39B and trailing P/E 25.6.
EDIT currently screens at market cap $375.2M. TRMB currently screens at market cap $11.39B and trailing P/E 25.6.
Not investment advice. Open the EDIT and TRMB stock pages for the full models.
Not investment advice.